SAREPTA THERAPEUTICS, INC. Deferred Revenue
SAREPTA THERAPEUTICS, INC. (SRPT) had Deferred Revenue of $3.30 million as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-10-31
- 2018-09-30: Deferred Revenue, Current $3.30M.
- 2018-06-30: Deferred Revenue, Current $3.30M.
- 2017-12-31: Deferred Revenue, Current $3.32M.
- 2017-09-30: Deferred Revenue, Current $3.30M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-09-30 | $3.30M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $3.30M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $3.32M 10-Q · filed 2018-10-31 |
| 2017-09-30 | $3.30M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $3.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $3.30M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.30M 10-K · filed 2018-03-01 |
| 2016-09-30 | $3.30M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $3.30M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.30M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.30M 10-K · filed 2017-02-28 |
| 2015-09-30 | $3.30M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $3.30M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $3.36M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $3.32M 10-K · filed 2016-02-25 |
| 2014-09-30 | $3.36M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $3.30M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.30M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.30M 10-K · filed 2015-02-26 |
| 2013-09-30 | $3.96M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $4.50M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.88M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.30M 10-K · filed 2014-03-03 |
| 2012-09-30 | $3.30M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $3.30M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $3.30M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $3.30M 10-K · filed 2013-03-15 |
| 2011-09-30 | $3.30M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $3.30M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $3.30M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |